print gohome
The Jerusalem Post - Israel News
 
US top court denies Teva stay in Copaxone patent fight
By REUTERS
04/18/2014
 
WASHINGTON - US Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd that would have prevented a lower court ruling from going into effect while the court considers an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.

The decision could help pave the way for generic competitors to go on the market as soon as next month.
print gohome
print

Copyright © 2014 Jpost Inc. All rights reserved • Terms of UsePrivacy Policy